RSV Vaccine Approved for Use in Pregnancy to Protect Infants
(MedPage Today) -- The FDA approved Pfizer's bivalent respiratory syncytial virus (RSV) prefusion F protein vaccine (Abrysvo) for use in pregnant individuals to protect newborns from serious RSV-related outcomes.
Even though the vaccine was administered...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | International Medicine & Public Health | Pfizer | Pregnancy | Respiratory Medicine | Vaccines